Is Repligen's Recent 18% Price Surge Justified After Broad Biotech Rally? [Yahoo! Finance]
Repligen Corporation (RGEN)
Last repligen corporation earnings: 2/20 07:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
repligen.com/investors
Company Research
Source: Yahoo! Finance
Repligen's share price has had a solid run recently, jumping 18.4% in just the last week and notching a 28.0% climb over the past month. That kind of near-term enthusiasm definitely gets attention, even though the year-to-date performance sits at a milder 4.0%. Zooming out, you'll see the one-year return is 8.8%. However, if you hold for years at a time, you might have noticed it has been a bit more of a rollercoaster. The three-year return dips to -29.1%, and over the last five years, it is at -12.8%. Some of this recent positive momentum seems tied to optimism around developments in the broader biotech sector, which have drawn new investor interest to names like Repligen. Still, it is fair to wonder if the stock's current price already includes that positive sentiment, or if there is room to run. When you look at Repligen through the lens of valuation, there is a story to uncover. Our valuation score puts Repligen at 1 out of 6 for being undervalued, which is a sign that, by mos
Show less
Read more
Impact Snapshot
Event Time:
RGEN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RGEN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RGEN alerts
High impacting Repligen Corporation news events
Weekly update
A roundup of the hottest topics
RGEN
News
- Repligen (NASDAQ:RGEN) had its "sell (d+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Repligen Corporation to Present at Evercore Healthcare Conference [Yahoo! Finance]Yahoo! Finance
- Repligen Corporation to Present at Evercore Healthcare ConferenceGlobeNewswire
- Why Repligen (RGEN) Stock Is Trading Up Today [Yahoo! Finance]Yahoo! Finance
- Repligen (NASDAQ:RGEN) had its "sell (d+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
RGEN
Earnings
- 10/28/25 - Beat
RGEN
Sec Filings
- 11/26/25 - Form 4
- 11/25/25 - Form 144
- 11/19/25 - Form 4
- RGEN's page on the SEC website